Bortezomib-Based Induction And Maintenance Overcomes The Negative Prognostic Impact Of Renal Impairment And Del17p In Transplant-Eligible Myeloma Patients: Long Term Results From The Phase Iii Hovon-65/Gmmg-Hd4 Study After Median 137 Months Follow Up
BLOOD(2019)
Abstract
Background:
MoreTranslated text
Key words
bortezomib-based,transplant-eligible
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined